The CEO of Optimi Health said he\u0027s been in discussion with Alberta government officials to possibly contribute to the field.
Since last week’s announcement, Ellis’s office has been deluged with inquiries about the new regulations and the possible expansion of the use of psychedelics, which currently are largely limited to anesthetic and hallucinogen ketamine in non-palliative therapy.Article content
“Our goal is to ensure patient protection from bad actors who could take advantage of patients who are in a mentally-altered state,” said Engler.Article content He noted that now, therapists granted Health Canada permission to employ psilocybin must source it from black market suppliers even as his pharmaceutical-grade fungi are banned from use.Article content
A dose of 2.5 grams of the mushrooms, he said, would produce “a really great trip that would take off close to the moon.” “We always intended to synthesize pharmaceutical-grade MDMA — there’s a shortage of supply,” said Ciprick.The operator of a clinic that employs ketamine welcomes Alberta’s regulations, predicting they’re a model that’ll be followed across Canada and could ultimately spur the approval of psychedelics like MDMA.
المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين
Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.
Goodfood CEO doesn't dismiss takeover possibility as pandemic boom fades - BNN BloombergGoodfood Market, whose stock sank Friday after the meal-kit company announced a significant impairment and a covenant breach, has had conversations with other parties about partnerships and its chief executive officer didn’t dismiss the possibility of an outright takeover.
اقرأ أكثر »
The mining sector has never been healthier even as sentiment stinks - Hawkmoon Resources CEOA roundup of all the mining news in the precious metals sector with a variety of company news, mining sector analysis, newsletter writer insights and executive interviews.
اقرأ أكثر »
Insurance firm rejects claim because prescriber was nurse practitionerCEO of Nurses and Nurse Practitioners of B.C. says it’s not the first time an insurance company has rejected a prescription from a nurse practitioner.
اقرأ أكثر »
Insiders buy as Whitecap Resources looks to the futureCEO Grant Fagerheim adds to his stake as the company hopes to reduce net debt to $1.8-billion by the end of 2022
اقرأ أكثر »
Hockey Canada: Calls for cultural change spark period of reckoning for sport - National | Globalnews.caEven after the entire board stepped down on Tuesday along with the CEO, corporate partners emphasized the need for additional measures before they would return.
اقرأ أكثر »